![]() United Therapeutics United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of innovative products to address the unmet medical needs of patients with chronic and life-threatening conditions. | ![]() PTC Therapeutics PTC Therapeutics is a biopharmaceutical company that engages in the discovery, development, and commercialization of small-molecule drugs. | ![]() Ionis Pharmaceuticals Ionis Pharmaceuticals (formerly known as Isis Pharmaceuticals) is a company that discovers and develops RNA-targeted therapeutics. | ![]() Sarepta Therapeutics Sarepta Therapeutics is a biopharmaceutical company specializing in the discovery and development of RNA-targeted therapeutics, gene therapy and, other genetic therapeutic modalities for the treatment of rare diseases. | ||
Founding Date | Founding Date 1942 | Founding Date 1996 | Founding Date 1998 | Founding Date 1989 | Founding Date 1980 |
Type | Type Public | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Trevose, US HQ Philadelphia, US | Locations Silver Spring, US HQ Magog, CA Nanjing, CN Shanghai, CN Mörfelden Walldorf, DE Surrey, GB Blacksburg, US see more | Locations South Plainfield, US HQ | Locations Carlsbad, US HQ | Locations Cambridge, US HQ Dublin, IE Zug, CH Providence, US |
Employees | Employees 81015% decrease | Employees 9207% increase | Employees 75448% increase | Employees 7577% decrease | Employees 8403% decrease |
Valuation ($) | Valuation ($) 65.4 m | Valuation ($) 10 b | Valuation ($) 3.2 b | Valuation ($) 5.1 b | Valuation ($) 12.1 b |
Twitter followers | Twitter followers N/A | Twitter followers 210 | Twitter followers 2 k | Twitter followers 4.4 k | Twitter followers 4.7 k |
Number of tweets (last 30 days) | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) 36 | Number of tweets (last 30 days) 16 | Number of tweets (last 30 days) 9 |
Average likes per tweet (last 30 days) | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) 4.3 | Average likes per tweet (last 30 days) 7.4 | Average likes per tweet (last 30 days) 16.6 |
Percentage of tweets with engagement (last 30 days) | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) 91.67% | Percentage of tweets with engagement (last 30 days) 93.75% | Percentage of tweets with engagement (last 30 days) 88.89% |
Employee Rating | Employee Rating 2.1 | Employee Rating 4.5 | Employee Rating 4.1 | Employee Rating 3.6 | Employee Rating 4.1 |
Financial | |||||
Revenue (est.) | Revenue (est.) $340.6m (FY, 2022) | Revenue (est.) $1.9b (FY, 2022) | Revenue (est.) $698.8m (FY, 2022) | Revenue (est.) $587.4m (FY, 2022) | Revenue (est.) $933m (FY, 2022) |
Cost of goods | Cost of goods N/A | Cost of goods $151.6m (FY, 2022) | Cost of goods N/A | Cost of goods $14.1m (FY, 2022) | Cost of goods N/A |
Gross profit | Gross profit $33.2m (FY, 2022) | Gross profit $1.8b (FY, 2022) | Gross profit N/A | Gross profit $573.3m (FY, 2022) | Gross profit N/A |
Net income | Net income ($231.6m) (FY, 2022) | Net income $727.3m (FY, 2022) | Net income ($559m) (FY, 2022) | Net income ($269.7m) (FY, 2022) | Net income ($703.5m) (FY, 2022) |
United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of innovative products to address the unmet medical needs of patients with chronic and life-threatening conditions.
View companyPTC Therapeutics is a biopharmaceutical company that engages in the discovery, development, and commercialization of small-molecule drugs.
View companyIonis Pharmaceuticals (formerly known as Isis Pharmaceuticals) is a company that discovers and develops RNA-targeted therapeutics.
View companySarepta Therapeutics is a biopharmaceutical company specializing in the discovery and development of RNA-targeted therapeutics, gene therapy and, other genetic therapeutic modalities for the treatment of rare diseases.
View company